Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gibson

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Experimental Gerontology|April 3, 2003
mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the IrishOwen A Ross, Rose McCormack, Lynn D Maxwell, et al.
Parkinsonism & Related Disorders|August 17, 2005
Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PDDavid Gosal, Owen A Ross, Joe Wiley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
Neuroscience Letters|May 12, 2009
Phactr2 and Parkinson's diseaseChristian Wider, Sarah J Lincoln, Michael G Heckman, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|July 22, 2024
Recombinant Antibody-Producing Stable CHOK1 Pool Stability StudyBailin Tu, Zhihong Lin, Jeff Moore, et al.
Parkinsonism & Related Disorders|August 30, 2008
Dopamine beta-hydroxylase -1021C>T association and Parkinson's diseaseOwen A Ross, Michael G Heckman, Alexandra I Soto, et al.
Parkinsonism & Related Disorders|September 16, 2008
Genetic variation of Omi/HtrA2 and Parkinson's diseaseOwen A Ross, Alexandra I Soto, Carles Vilariño-Güell, et al.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Experimental Gerontology|April 3, 2003
mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the IrishOwen A Ross, Rose McCormack, Lynn D Maxwell, et al.
Parkinsonism & Related Disorders|August 17, 2005
Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PDDavid Gosal, Owen A Ross, Joe Wiley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
Neuroscience Letters|May 12, 2009
Phactr2 and Parkinson's diseaseChristian Wider, Sarah J Lincoln, Michael G Heckman, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|July 22, 2024
Recombinant Antibody-Producing Stable CHOK1 Pool Stability StudyBailin Tu, Zhihong Lin, Jeff Moore, et al.
Parkinsonism & Related Disorders|August 30, 2008
Dopamine beta-hydroxylase -1021C>T association and Parkinson's diseaseOwen A Ross, Michael G Heckman, Alexandra I Soto, et al.
Parkinsonism & Related Disorders|September 16, 2008
Genetic variation of Omi/HtrA2 and Parkinson's diseaseOwen A Ross, Alexandra I Soto, Carles Vilariño-Güell, et al.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
Pageof 13